OBJECTIVES The aim of this study was to examine skeletal muscle mitochondria content, oxidative capacity, and the expression of key mitochondrial dynamics proteins in patients with heart failure with preserved ejection fraction (HFpEF), as well as to determine potential relationships with measures of exercise performance.
H eart failure with preserved left ventricular ejection fraction (HFpEF) is the most prevalent form of heart failure (HF) and is nearly unique to older adults, particularly older women (1, 2) . The primary manifestation of chronic stable HFpEF is severe exercise intolerance, measured objectively as reduced peak exercise oxygen uptake (peak VO 2 ) (3). Multiple recent reports indicate that in addition to underlying cardiac dysfunction, noncardiac factors contribute to severe exercise intolerance in HFpEF. Previously, our group has reported that reduced cardiac output accounts for only 50% of the markedly reduced peak oxygen uptake (peak VO 2 ) in HFpEF patients (4) , which suggests a significant role for peripheral factors. Endurance exercise training significantly improves peak VO 2 in older people in clinically stable condition with HFpEF; however, a majority of the improvement is mediated by noncardiac factors, presumably skeletal muscle function (5, 6 ). Although we and others have found significant abnormalities in central arterial stiffness and have investigated their relation to exercise intolerance, we have reported that arterial stiffness and conduit arterial endothelial dysfunction do not improve with exercise training in HFpEF (7) . Altogether, these studies suggest that in HFpEF, skeletal muscle alterations contribute to exercise intolerance and that improvements in skeletal muscle function contribute to the beneficial effects of exercise training for these patients.
Several lines of evidence indicate that older adults
with HFpEF have altered skeletal muscle metabolism.
We (8) reported that older HFpEF patients have abnormal skeletal muscle oxygen utilization and that this is related to their severely reduced peak VO 2 . Using magnetic resonance spectroscopy in HFpEF patients, Bhella et al. (9) found reduced skeletal muscle oxidative metabolism. More recently, Dhakal et al. (10) , using invasive hemodynamic monitoring during exercise, showed that oxygen extraction was significantly reduced in HFpEF and was a major contributor to reduced peak VO 2 . Although patients with HFpEF have a lower percent lean mass, the increase in peak exercise VO 2 relative to lean mass is lower in patients with HFpEF than in healthy control subjects (8) . Using skeletal muscle biopsy samples, we recently showed that patients with HFpEF have a decreased number of type I oxidative fibers compared with healthy control subjects (11) . Taken together, these data suggest the hypothesis that skeletal muscle mitochondrial dysfunction contributes to impaired skeletal muscle aerobic metabolism in patients with HFpEF.
To examine this hypothesis, we measured the expression of key mitochondrial proteins in skeletal muscle biopsy specimens from patients with HFpEF and healthy, agematched, control subjects (HCs). We measured the expression of mitofusins (Mfn) 1 and 2, proteins localized to the mitochondrial outer membrane that play an essential role in the fusion of these organelles. Mitofusins, in particular Mfn2, play an important role in mitochondrial quality control by mediating complementation of organelles and the elimination of dysfunctional mitochondria by autophagy (12, 13) . A potential difference in skeletal muscle mitochondrial content was determined by analysis of porin expression. Further validation was provided by measurement of citrate synthase activity, a biomarker widely recognized as the most reliable indicator of skeletal muscle oxidative capacity and mitochondrial content (14) . Finally, we examined the relationships of these mitochondrial parameters with measures of exercise intolerance, peak VO 2 and 6-min walk distance (6MWD).
METHODS

PARTICIPANTS.
As previously described in studies from our laboratory (3, 4, 6, (15) (16) (17) , and in accordance (ejection fraction $50% and no segmental wall motion abnormalities), and no significant ischemic or valvular heart disease, pulmonary disease, anemia, or other disorder that could explain the patient's symptoms (3, 4, 16) . HFpEF subjects were $60 years of age at study entry. Sedentary HC subjects were recruited and screened and were excluded if they had any chronic medical illness, were taking any chronic medication, had current Mfn = mitofusin EXERCISE TESTING. As described previously (3, 17) , exercise testing was performed on a treadmill with the modified Naughton protocol for HFpEF subjects and the modified Bruce protocol for HCs. Expired gas analysis was conducted with a commercially available system (CPX-2000 and Ultima, MedGraphics, Minneapolis, Minnesota) that was calibrated before each test with a standard gas of known concentration and volume. Breath-by-breath gas exchange data were measured continuously during exercise and averaged every 15 s, and peak values were averaged from the last 2 15-s intervals during peak exercise. A 6MWD was performed by the method of Guyatt et al. (22) .
SKELETAL MUSCLE BIOPSY. As described previously, skeletal muscle biopsies were performed in the early morning after an overnight fast (23) (24) (25) . Subjects were asked to refrain from taking aspirin, nonsteroidal anti-inflammatory drugs, and other compounds that could affect bleeding, platelets, or bruising for the week before the biopsy and to refrain from any strenuous activity for at least 36 h before the biopsy. Molina et al.
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All statistical tests were conducted with SAS version Expression of mitochondrial proteins and citrate synthase activity was compared with aerobic power (i.e., peak VO 2 ) and endurance (6MWD) ( Table 4) .
With all subjects combined, porin expression was significantly and positively associated with both peak Values are mean AE SD or n (%).
DEXA ¼ dual-energy x-ray absorptiometry; HC ¼ healthy age-matched control subjects; HFpEF ¼ heart failure with preserved ejection fraction; NYHA ¼ New York Heart Association. EFFECTS OF STATIN USE. By definition, no participants in the HC group were taking statin medications.
Among the participants with HFpEF, 11 were taking statins and 9 were not. Analyses comparing the effects of statin use on mitochondrial outcomes indicated that there was no effect on Mfn2 expression (p ¼ 0.67) and no effect of citrate synthase activity (p ¼ 0.94).
DISCUSSION
To the best of our knowledge, this study provides the first report of skeletal muscle mitochondrial alterations in patients with HFpEF, the most common form of HF in older persons. The major new finding of this study is that compared with HCs, patients with HFpEF exhibit lower vastus lateralis mitochondrial content and oxidative capacity as assessed by citrate synthase activity and porin expression. The relationships of these mitochondrial parameters with measures of exercise capacity indicate that these deficits might contribute to severely reduced exercise tolerance. Additionally, the mitochondrial fusion regulator, Mfn2, was significantly decreased in HFpEF and might also contribute to exercise intolerance.
The findings presented in this report are supported by multiple lines of evidence, including a recent study reporting that mitochondrial density, measured in the soleus muscle of a rat model of HFpEF, was reduced compared with control animals (33) . Further support is provided by our previous report that compared with age-matched healthy subjects, older HFpEF patients have reduced peak exercise arteriovenous oxygen difference, which is an important contributor to their severely reduced peak VO 2 (4). In addition, noncardiac peripheral factors were also a major contributor to improved peak VO 2 after endurance training (6). Using 31 P magnetic resonance spectroscopy, Bhella et al. (9) reported that during static leg exercise, HFpEF patients had impaired Values are mean AE SD. *Adjusted for sex and presented as least square means AE SE; p value corresponds to adjusted data.
Abbreviations as in Table 1 . GAPDH ¼ glyceraldehyde-3-phosphate dehydrogenase; other abbreviations as in Table 1 .
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A U G U S T 2 0 1 6 : 6 3 6 -4 5 skeletal muscle oxidative metabolism compared with healthy control subjects. Recently, we showed that compared with healthy age-matched control subjects, the slope of the relationship of peak VO 2 with percent leg lean mass was markedly reduced in older patients with HFpEF, which suggests that skeletal muscle hypoperfusion or impaired oxygen utilization may play an important role in limiting exercise performance in HFpEF (8) . Furthermore, using skeletal muscle biopsy samples, we showed that patients with HFpEF had fewer type I oxidative fibers than healthy control subjects (11) . 
Citrate synthase activity (nmol/min/mg)
The p values are 2-tailed.
GAPDH ¼ glyceraldehyde-3-phosphate dehydrogenase; VO2 ¼ oxygen uptake; 6MWD ¼ 6-min walk distance. We selected HCs who were sedentary because habitual levels of physical activity can influence skeletal muscle function. Because we did not use formal survey assessments of habitual physical activity, we cannot ensure that there were not subtle intergroup differences that influenced our results.
However, similar mitochondrial abnormalities were present in animal models of HF and HFpEF in which physical activity was able to be controlled (33) .
Furthermore, it is known that mitochondrial abnormalities in HFrEF, which are similar to those we observed in our patients with HFpEF, are independent of level of habitual physical activity and cardiac output (36, 49) .
Although relationships of mitochondrial function variables with exercise capacity became less significant when examined within the HFpEF group only, the most appropriate analysis to address the question of mechanisms accounting for differences in exercise capacity between HFpEF and control subjects is with the groups combined; this also allows a larger range for correlations and a larger sample size.
Because we did not test a control group with hypertension but not HF, we cannot determine whether a portion of the intergroup differences in mitochondrial content and biogenesis that we observed was mediated in part by this common comorbidity.
FUTURE DIRECTIONS. The results of this study warrant multiple lines of future investigation. We have previously reported that the capillary-to-fiber ratio is decreased in patients with HFpEF and that these alterations are associated with decreased peak VO 2 (25) . 
